Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
Select a question to fill the search bar, then submit it or edit it first.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| diagnostic aids; (phenylcarbamoyl)methyl iminodiacetic acid derivatives | 3332 | 78266-06-5 |
None
None
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| kinase-safety-class | ACVR2A,ACVR2B,ACVRL1,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK5,CDK9,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,GRK2,GSK3B,IKBKB,ITK,JAK1,JAK2,JAK3,MAP2K6,MAP3K21,MAP3K7,MAPK10,MAPK12,MAPK7,MAPK9,MAPKAPK2,MTOR,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIM2,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ZAP70 | 53 | |||
| kinase-selectivity-class | AXL,BRAF,CDK9,DDR1,EPHB4,ERBB2,GRK2,MAP2K6,MAPK7,PIK3CD,PRKDC,TEK | 12 | |||
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 |
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Multiple use of single-use product | 190.05 | 110.78 | 21 | 35 | 1802 | 90626589 |
None
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Multiple use of single-use product | 270.30 | 139.33 | 28 | 43 | 1268 | 110587960 |
None
None
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 1.35 | acidic |
| pKa2 | 2.54 | acidic |
| pKa3 | 12.95 | acidic |
| pKa4 | 7.72 | Basic |
None
None
None
| ID | Source |
|---|---|
| D04869 | KEGG_DRUG |
| 4038253 | VANDF |
| C1337345 | UMLSCUI |
| CHEBI:135608 | CHEBI |
| CHEMBL1605443 | ChEMBL_ID |
| DB15779 | DRUGBANK_ID |
| C000714007 | MESH_SUPPLEMENTAL_RECORD_UI |
| 54158 | PUBCHEM_CID |
| 5184 | INN_ID |
| 7PV0B6ED98 | UNII |
| 1311500 | RXNORM |
| 25101 | MMSL |
| d07088 | MMSL |
| 009840 | NDDF |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Choletec | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0270-0083 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 45 mg | INTRAVENOUS | NDA | 17 sections |
| Kit for the Preparation of Technetium Tc 99m Mebrofenin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 45567-0455 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 45 mg | INTRAVENOUS | ANDA | 15 sections |
| Mebrofenin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51808-216 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 10 mg | INTRAVENOUS | Unapproved drug other | 5 sections |